Platelet Count
PRP injections with high platelet concentrations may improve outcomes for knee OA
Published results showed platelet concentration may impact clinical outcomes for patients who receive platelet-rich plasma injections for knee osteoarthritis, as injections with higher platelet counts were associated with superior outcomes.
Platelet count may be linked with 30-day in-hospital mortality in patients with ESKD
There may be a nonlinear connection between platelet count and 30-day in-hospital mortality in patients with end-stage kidney disease in the ICU, according to researchers.
Lower platelet count a predictor for ruxolitinib-induced thrombocytopenia
Inflammation marker may predict 30-day complications of acute MI
Patients hospitalized for acute MI with a high platelet-to-lymphocyte ratio are up to three times more likely to experience major adverse CV events in the 30 days after undergoing PCI, researchers reported.
PCI safe in patients with cancer, thrombocytopenia; use is increasing
ATLANTA — Researchers observed that PCI in patients with cancer is safe, regardless of cancer type or concomitant thrombocytopenia, and its use increased over time.
Top in hem/onc: Discrimination toward trainees, increased platelet counts and cancer risk
A recent study showed that patients often display discriminatory behavior toward hematology and oncology trainees.
High platelet count associated with increased risk for certain cancers
Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association especially strong in colon, lung, ovarian and stomach cancers, according to a nested case-control study in JAMA Network Open.
AVID200 improves platelet counts among patients with advanced myelofibrosis
AVID200 led to significant reduction in serum transforming growth factor beta levels and improved platelet counts among patients with advanced myelofibrosis, according to study results presented at ASH Annual Meeting and Exposition.
Coagulopathies may be associated with adverse events after THA, TKA
Coagulopathies such as low platelet counts, lengthy partial thromboplastin time and a high international normalized ratio may be risk factors for adverse events following total hip and knee arthroplasties, according to published results.
Volanesorsen decreases triglycerides in familial chylomicronemia syndrome
Volanesorsen reduced triglycerides in 77% of patients with familial chylomicronemia syndrome to less than 750 mg/dL, according to a study published in The New England Journal of Medicine.